The TRPA1 channel is a cardiac target of mIGF-1/SIRT1 signaling

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 307, Issue 7, 2014, Pages H939-H944

  Pazienza, Valerio ^a   Pomara, Cristoforo ^b,c   Cappello, Francesco ^d,e   Calogero, Raffaele ^f   Carrara, Matteo ^f   Mazzoccoli, Gianluigi ^a   Vinciguerra, Manlio ^a,e,g  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF MALTA   (Malta)

^c UNIVERSITY OF FOGGIA   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

^e Euro Mediterranean Institute of Science and Technology   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Heart; Insulin like growth factor 1; Member 1; Sirtuin 1; Subfamily A; Transient receptor potential cation channel

Indexed keywords

GROWTH FACTOR; N (4 ISOPROPYLPHENYL) 2 (1,2,3,6 TETRAHYDRO 1,3 DIMETHYL 2,6 DIOXO 7H PURIN 7 YL)ACETAMIDE; SIRTUIN 1; SOMATOMEDIN C; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; 2-(1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL)-N-(4-ISOPROPYLPHENYL)ACETAMIDE; ACETANILIDE DERIVATIVE; INSULIN-LIKE GROWTH FACTOR-1, MOUSE; PURINE DERIVATIVE; SIRT1 PROTEIN, MOUSE; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRPA1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BORDERLINE HYPERTENSION; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; HEART; HEART MUSCLE; HEART MUSCLE CELL; HEART PROTECTION; MOUSE; NONHUMAN; PAIN; SENSORY NERVE CELL; TRANSGENE; ANIMAL; ANTAGONISTS AND INHIBITORS; GENETICS; METABOLISM; PROMOTER REGION; SIGNAL TRANSDUCTION;

ACETANILIDES; ANIMALS; BLOOD PRESSURE; INSULIN-LIKE GROWTH FACTOR I; MICE; MYOCYTES, CARDIAC; PROMOTER REGIONS, GENETIC; PURINES; SIGNAL TRANSDUCTION; SIRTUIN 1; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84907662058     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00150.2014     Document Type: Article

References (30)

1. Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, Tian B, Wagner T, Vatner SF, Sadoshima J. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 100: 1512-1521, 2007.
2. Bautista DM, Pellegrino M, Tsunozaki M. TRPA1: a gatekeeper for inflammation. Annu Rev Physiol 75: 181-200, 2013.
3. Bolasco G, Calogero R, Carrara M, Banchaabouchi MA, Bilbao D, Mazzoccoli G, Vinciguerra M. Cardioprotective mIGF-1/SIRT1 signaling induces hypertension, leukocytosis and fear response in mice. Aging (Albany NY) 4: 402-416, 2012.
4. Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P, Bronson R, Appella E, Alt FW, Chua KF. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 100: 10794-10799, 2003.
5. Chong ZZ, Wang S, Shang YC, Maiese K. Targeting cardiovascular disease with novel SIRT1 pathways. Future Cardiol 8: 89-100, 2012.
6. Earley S. TRPA1 channels in the vasculature. Br J Pharmacol 167: 13-22, 2012.
7. Fontana L, Vinciguerra M, Longo VD. Growth factors, nutrient signaling, and cardiovascular aging. Circ Res 110: 1139-1150, 2012.
8. Gems D, Partridge L. Stress-response hormesis and aging: “that which does not kill us makes us stronger”. Cell Metab 7: 200-203, 2008.
9. Guarente L. Franklin H. Epstein lecture: sirtuins, aging, and medicine. N Engl J Med 364: 2235-2244, 2011.
10. Gurniak CB, Perlas E, Witke W. The actin depolymerizing factor n-cofilin is essential for neural tube morphogenesis and neural crest cell migration. Dev Biol 278: 231-241, 2005.
11. Jaquemar D, Schenker T, Trueb B. An ankyrin-like protein with transmembrane domains is specifically lost after oncogenic transformation of human fibroblasts. J Biol Chem 274: 7325-7333, 1999.
12. Julius D. TRP channels and pain. Annu Rev Cell Dev Biol 29: 355-384, 2012.
13. Kaneko Y, Szallasi A. Transient receptor potential (TRP) channels: a clinical perspective. Br J Pharmacol 171: 2474-2507, 2014.
14. Kratsios P, Catela C, Salimova E, Huth M, Berno V, Rosenthal N, Mourkioti F. Distinct roles for cell-autonomous Notch signaling in cardiomyocytes of the embryonic and adult heart. Circ Res 106: 559-572, 2010.
15. Kwan KY, Allchorne AJ, Vollrath MA, Christensen AP, Zhang DS, Woolf CJ, Corey DP. TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell transduction. Neuron 50: 277-289, 2006.
16. Oberdoerffer P, Michan S, McVay M, Mostoslavsky R, Vann J, Park SK, Hartlerode A, Stegmuller J, Hafner A, Loerch P, Wright SM, Mills KD, Bonni A, Yankner BA, Scully R, Prolla TA, Alt FW, Sinclair DA. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 135: 907-918, 2008.
17. Potenza N, Vecchione C, Notte A, De Rienzo A, Rosica A, Bauer L, Affuso A, De Felice M, Russo T, Poulet R, Cifelli G, De Vita G, Lembo G, Di Lauro R. Replacement of K-Ras with H-Ras supports normal embryonic development despite inducing cardiovascular pathology in adult mice. EMBO Rep 6: 432-437, 2005.
18. Pozsgai G, Bodkin JV, Graepel R, Bevan S, Andersson DA, Brain SD. Evidence for the pathophysiological relevance of TRPA1 receptors in the cardiovascular system in vivo. Cardiovasc Res 87: 760-768, 2010.
19. Rattan SI. Hormesis in aging. Ageing Res Rev 7: 63-78, 2008.
20. Santini MP, Lexow J, Borsellino G, Slonimski E, Zarrinpashneh E, Poggioli T, Rosenthal N. IGF-1Ea induces vessel formation after injury and mediates bone marrow and heart cross-talk through the expression of specific cytokines. Biochem Biophys Res Commun 410: 201-207, 2011.
21. Santini MP, Tsao L, Monassier L, Theodoropoulos C, Carter J, Lara-Pezzi E, Slonimsky E, Salimova E, Delafontaine P, Song YH, Bergmann M, Freund C, Suzuki K, Rosenthal N. Enhancing repair of the mammalian heart. Circ Res 100: 1732-1740, 2007.
22. Sohal DS, Nghiem M, Crackower MA, Witt SA, Kimball TR, Tymitz KM, Penninger JM, Molkentin JD. Temporally regulated and tissue- specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res 89: 20-25, 2001.
23. Tanno M, Kuno A, Yano T, Miura T, Hisahara S, Ishikawa S, Shimamoto K, Horio Y. Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem 285: 8375-8382, 2010.
24. Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y. Nucleocy- toplasmic shuttling of the NAD -dependent histone deacetylase SIRT1. J Biol Chem 282: 6823-6832, 2007.
25. Tonkin J, Villarroya F, Puri PL, Vinciguerra M. SIRT1 signaling as potential modulator of skeletal muscle diseases. Curr Opin Pharmacol 12: 372-376, 2012.
26. Vinciguerra M, Fulco M, Ladurner A, Sartorelli V, Rosenthal N. SirT1 in muscle physiology and disease: lessons from mouse models. Dis Model Mech 3: 298-303, 2010.
27. Vinciguerra M, Hede M, Rosenthal N. Comments on Point:Counter- point: IGF is/is not the major physiological regulator of muscle mass. IGF-1 is a major regulator of muscle mass during growth but not for adult myofiber hypertrophy. J Appl Physiol 108: 1829-1830, 2010.
28. Vinciguerra M, Musaro A, Rosenthal N. Regulation of muscle atrophy in aging and disease. Adv Exp Med Biol 694: 211-233, 2010.
29. Vinciguerra M, Santini MP, Claycomb WC, Ladurner AG, Rosenthal N. Local IGF-1 isoform protects cardiomyocytes from hypertrophic and oxidative stresses via SirT1 activity. Aging (Albany NY) 2: 43-62, 2009.
30. Vinciguerra M, Santini MP, Martinez C, Pazienza V, Claycomb WC, Giuliani A, Rosenthal N. mIGF-1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart. Aging Cell 11: 139-149, 2012.